Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Xultophy
Pharma
Sanofi's Soliqua bests premixed insulin in head-to-head study
With new trial data presented at the American Diabetes Association's 81st Scientific Sessions on Monday, Sanofi is looking to give Soliqua a boost.
Eric Sagonowsky
Jun 28, 2021 10:00am
Novo petitions FDA to require Victoza copies to go through clinical trials
Oct 9, 2017 2:55pm
Xultophy beats rivals at reining in CV risk factors: Analysis
Sep 13, 2017 10:31am
Hot diabetes news from ADA: J&J, Lilly, Novo, Sanofi, et al.
Jun 12, 2017 10:24am
New Novo combo Xultophy looks for edge with ADA data win
Jun 11, 2017 2:58pm
Sanofi beats Novo to launch with diabetes combo Soliqua
Jan 6, 2017 11:15am
